Efficacy and safety of the S 05985 combination compared with each individual component: randomised, double-blind, placebo-controlled study over eight weeks in hypertensive patients

Phase 2

Completed

• Conditions: Essential arterial hypertension; Circulatory System; Hypertension

• Registration Number: ISRCTN14235381
• Lead Sponsor: Institut de Recherches Internationales Servier (France)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-01-23
• Study Completion: 2008-07-15
• Last Update Posted: 4 May 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1581

Inclusion Criteria

1. Men or women
2. 18 to 80 years
3. Essential uncomplicated mild to moderate hypertensive patients

Exclusion Criteria

1. Very high cardiovascular risk patients
2. Severe disease
3. Pregnancy
4. Obesity
5. Secondary hypertension

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in blood pressure measured before and after 2, 4 and 8 weeks

Secondary Outcome Measures

Name	Time	Method
<br> 1. Response to the treatment and normalisation of blood pressure<br> 2. Safety<br> Measured before and after 2, 4 and 8 weeks<br>